Journal of Substance Abuse Treatment
Volume 30, Issue 3 , Pages 253-259 , April 2006

An intervention program for ADHD in patients with substance use disorders: Preliminary results of a field trial

  • M. Anne Goossensen, Ph.D.

      Affiliations

    • Institute of Health Policy and Management, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 010 408 8712.
    • ,
  • Geurt van de Glind, M.A.

      Affiliations

    • Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands
    • ,
  • Pieter-Jan Carpentier, M.D.

      Affiliations

    • Reinier van Arkel Groep, 's-Hertogenbosch and Novadic-Kentron, Network for Addiction Treatment Services, Sint-Oedenrode, The Netherlands
    • ,
  • Riek M.A. Wijsen, M.A.

      Affiliations

    • De Grift, Regional Addiction Treatment Centre Gelderland, The Netherlands
    • ,
  • Daniëlle van Duin, M.Sc.

      Affiliations

    • Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands
    • ,
  • J.J. Sandra Kooij, M.D.

      Affiliations

    • PsyQ, Department of Adult ADHD, The Hague, The Netherlands

Received 18 July 2005 ,Revised 12 December 2005 ,Accepted 20 December 2005.

References 

  1. Biederman J, Faraone SV, Spencer T. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry. 1993;150:1792–1798
  2. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104:1–5
  3. Castaneda R, Levy R, Hardy M, Trujillo M. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatric Services. 2000;51:169–171
  4. Clure C, Brady KT, Saladin ME, Johnson R, Rittenbury M. Attention-deficit/hyperactivity disorder and substance use: Symptom pattern and drug choice. American Journal of Drug and Alcohol Abuse. 1999;25:441–448
  5. Ferdinand RF, Verhulst FC. The prevalence of self-reported problems in young adults from the general population. Social Psychiatry and Psychiatric Epidemiology. 1996;31:10–20
  6. Kessler RC. Prevalence of adult ADHD in the United States: Results from the National Comorbidity Survey Replication (NCS-R). In: Presented at the 2004 annual meeting of the American Psychiatric Association. 2004;
  7. King VL. Attention deficit disorder and treatment outcome in opioid abusers entering treatment. Journal of Nervous and Mental Disease. 1999;187:487–495
  8. Kooij JJS. ADHD bij volwassenen. Inleiding in Diagnostiek en behandeling. 2nd ed.. Lisse: Swets & Zeitlinger Publishers; 2003;
  9. Kooij JJS, Buitelaar JK, van Tilburg W. Voorstel voor diagnostiek en behandeling van aandachtstekortstoornis met hyperactiviteit (ADHD) op volwassen leeftijd. Tijdschrift voor Psychiatrie. 1999;41:349–358
  10. Kooij JJS, Burger H, Boonstra AM, van der Linden PD, Kalma LE, Buitelaar JK. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder (ADHD). A randomised placebo-controlled double-blind cross-over trial. Psychological Medicine. 2004;34:973–981
  11. Kooij JJS, van den Oord EJ, Buitelaar JK, Furer JW, Rijnders CA, Hodiamont PP. Internal and external validity of attention-deficit/hyperactivity disorder in a population-based sample of adults. Psychological Medicine. 2005;35:817–827
  12. Levin FR, Evans SM, Kleber HD. Practical guidelines for the treatment of substance abusers with adult attention-deficit hyperactivity disorder. Psychiatric Services. 1999;50:1001–1003
  13. Levin FR, Evans SM, McDonnel DM, Kleber HD. Methylphenidate treatment for cocaine abusers with adult attention-deficit hyperactivity disorder. A pilot study. Journal of Clinical Psychiatry. 1998;58:300–305
  14. Lynskey MT, Hall W. Attention Deficit Hyperactivity Disorder and substance use disorders: Is there a causal link?. Addiction. 2001;96:815–822
  15. Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Archives of General Psychiatry. 1984;41:1059–1063
  16. Mc Dermott SP. Cognitive therapy in adults with ADHD. In:  Brown TE editors. Attention-deficit disorders and comorbidities in children, adolescents and adults. Arlington, VA: American Psychiatric Press; 2000;p. 361–387
  17. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. How to practise and teach EBM. Edinburgh: Churchill Livingstone; 2000;
  18. Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive–behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behaviour Research and Therapy. 2005;43:831–842
  19. Schubiner H, Saules KK, Arfken CL, Johanson CE, Schuster CR, Lockhart N, et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology. 2002;10:286–294
  20. Schubiner H, Tselepsis A, Isaacson LH, Warbasse M, Musial J. The dual diagnosis of Attention-Deficit/Hyperactivity Disorder and substance abuse: Case reports and literature review. Journal of Clinical Psychiatry. 1995;56:146–150
  21. Schubiner H, Tzelepsis A, Milberger S, Lockhart N, Kruger M, Kelley BJ, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. Journal of Clinical Psychiatry. 2000;61:244–251
  22. Somoza EC, Winhusen TM, Bridge TP, Rotrosen JP, Vanderburg DG, Harrer JM, et al. An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. Journal of Addiction Disorders. 2004;23:77–92
  23. Spencer T, Wilens TE, Biederman J, Faraone SV, Ablon S, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Archives of General Psychiatry. 1995;52:434–443
  24. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Archives of General Psychiatry. 1999, Dec;56:1073–1086
  25. van de Glind G, Eland A, Janssen M. ADHD en Verslaving. Een literatuuronderzoek naar de samenhang tussen ADHD en verslavingsproblemen. Maandblad Geestelijke volksgezondheid. 2001;537–555
  26. Wilens TE. Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs. 2003;63:2395–2411
  27. Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: The nature of the relationship, subtypes at risk, and treatment issues. Psychiatric Clinics of North America. 2004, June;27:283–301
  28. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003, January;111:179–185
  29. Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, et al. Buproprion XL in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled study. Biological Psychiatry. 2005;57:793–801

☆ This project was supported by ZonMw, The Netherlands Organization for Health Research and Development (grant 310-00-029).

PII: S0740-5472(06)00008-0

doi: 10.1016/j.jsat.2005.12.004

Journal of Substance Abuse Treatment
Volume 30, Issue 3 , Pages 253-259 , April 2006

Article Tools

* Image Usage & Resolution